SetPoint® System Used for First Time in Pacific Northwest to Treat Patients with Rheumatoid Arthritis in Clinical Practice

RegulatoryapprovedSetPoint® SystemPositive

AI Analysis

Summary

SetPoint Medical's SetPoint® System, an FDA-approved neuroimmune modulation therapy for rheumatoid arthritis, has been used for the first time in the Pacific Northwest, expanding patient access across the United States.

Outcome Details

FDA-approved neuroimmune modulation therapy for rheumatoid arthritis

Importance:4/10

Sentiment:

0.60

FDA ApprovalNeuroimmune ModulationRheumatoid ArthritisCommercial ExpansionMedical Device

Related Companies

$NWBO $MDCE $UTHR $TRAX

Read the original article

Published by PR Newswire Biotech on September 16, 2026 12:00 PM

Read Original